Cytodyn Inc (CYDY)

[GreenBioAnalyst]

OTC is the wild west and it's where a lot of the outlaws die young tomorrow and Wednesday morning. Tsk.tsk.tsk. Shorts reckoning is coming. Unfortunately, these parasites will not be able to cover until Wednesday morning. Time for them to find their personalized tombstone, I guess. Thank you for your business!

As I said before, CD12 will achieve statistically significant tomorrow at 5 p.m. ET., and enough to halt and gain an EUA from the FDA in the next few days. The best part of CD12? The company can apply for their CD10 approval as well. Here's what the previous CD10 results were:

Leronlimab (PRO 140), demonstrated improvement in total clinical symptom score at day 3 in patients with mild-to-moderate symptoms from coronavirus disease 2019 (COVID-19). The humanized igG4 monoclonal antibody also induced a statistically significant improvement in the National Early Warning Score 2 scale, a key secondary endpoint of phase 2 CD10 clinical trial, CytoDyn, Inc announced in a press release.

I'm looking for the company to generate $600m-$800m in revenues for CV19 therapeutics with a P/S of 24X. This a game-changing oncology drug. Don't fight it!